Tomographic Technologies (TomTec) of Munich has established aU.S. subsidiary to help commercialize its innovative cine three-dimensional(or 4-D, with time as the fourth dimension) ultrasound scannerfor cardiac applications. The German company, formed by
Tomographic Technologies (TomTec) of Munich has established aU.S. subsidiary to help commercialize its innovative cine three-dimensional(or 4-D, with time as the fourth dimension) ultrasound scannerfor cardiac applications. The German company, formed by a groupof former Kontron imaging engineers, showed its Echo-CT scannerat the American Heart Association meeting in Anaheim, CA, lastNovember (SCAN 12/4/91).
"We are formulating our marketing plans while awaitingFDA 510(k) clearance to market Echo-CT in the U.S.," saidIvan Young, president of the new TomTec company.
The U.S. subsidiary, headquartered in El Toro, CA, will beresponsible for marketing, sales and servicing the system in NorthAmerica. Young was formerly an ultrasound manager with ToshibaAmerica Medical Systems.
The Echo-CT system is based on a patented transesophageal echocardiography(TEE) probe that permits the ultrasound transducer to move freelyup and down a rigid tube and acquire dynamic images of the heart.
The TEE probe has a fully flexible assembly of multiple, semicircularplastic segments at the distal end. After insertion through thepatient's esophagus, the end of the probe is mechanically straightenedby the surgeon to form a rigid tube, enabling the transducer tobe moved up and down, providing exact parallel slices.
A stepping motor attached to the system helps move the transducerup the tube in time with the patient's cardiac R-R interval andrespiration. The transducer is equipped with a water-filled balloonin order to achieve optimal contact with the esophagus. The systemcan store images with a maximal frame-rate of 30 frames per second.
Images are reconstructed in about 15 minutes following removalof the transducer, Young said.
"This technology is comparable to the introduction of2-D (ultrasound) technology, which made high-performance color-flowimages possible. Now we are adding the fourth dimension, or movement,to this (3-D) technology," he said.
Echo-CT is in use in Europe and in clinical trials at the Universityof Kentucky in Lexington.
"We are encouraged by the initial test results, whichwill be presented at the next American Heart Association meeting,"Young said.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.